In patients with early‐stage breast cancer treated with postoperative aromatase inhibitors, treatment significantly increased the prevalence and severity of RLS, and sleep quality was found to be statistically poorer in patients with RLS compared with patients without RLS [33]. The gene discussed is CYP19A1; the disease is breast carcinoma.